135 related articles for article (PubMed ID: 32672875)
1. PAX3 silencing inhibits prostate cancer progression through the suppression of the TGF-β/Smad signaling axis.
Zeng K; Xie W; Huang J; Yang J; Deng K; Luo X
Cell Biol Int; 2020 Oct; 44(10):2131-2139. PubMed ID: 32672875
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
3. Fus knockdown inhibits the profibrogenic effect of cardiac fibroblasts induced by angiotensin II through targeting Pax3 thereby regulating TGF-β1/Smad pathway.
Wang G; Wu H; Liang P; He X; Liu D
Bioengineered; 2021 Dec; 12(1):1415-1425. PubMed ID: 33896391
[TBL] [Abstract][Full Text] [Related]
4. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
Qi G; Lu G; Yu J; Zhao Y; Wang C; Zhang H; Xia Q
Eur J Pharmacol; 2019 Oct; 860():172551. PubMed ID: 31323225
[TBL] [Abstract][Full Text] [Related]
6. Wulong Xiaozheng Wan medicated serum inhibits epithelial-mesenchymal transition in human gastric carcinoma cell line BGC823 by modulation of transforming growth factor-β1/Smad signaling.
Zhang Y; Wang B; Yang L; Li D; Yuan X; Guo X
J Tradit Chin Med; 2019 Jun; 39(3):380-392. PubMed ID: 32186010
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Wilms' Tumor Proliferation and Invasion by Blocking TGF-
Shi Q; Wu H; Li Y; Shen L; Tian X; Lin T; Wei G
Biomed Res Int; 2020; 2020():8039840. PubMed ID: 33282954
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer.
Huo W; Zhu XM; Pan XY; Du M; Sun Z; Li ZM
Math Biosci Eng; 2019 May; 16(5):4607-4621. PubMed ID: 31499680
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
13. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
[TBL] [Abstract][Full Text] [Related]
14. Verbascoside inhibits the epithelial-mesenchymal transition of prostate cancer cells through high-mobility group box 1/receptor for advanced glycation end-products/TGF-β pathway.
Wu CH; Chen CH; Hsieh PF; Lee YH; Kuo WW; Wu RC; Hung CH; Yang YL; Lin VC
Environ Toxicol; 2021 Jun; 36(6):1080-1089. PubMed ID: 33522686
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
Sun B; Fan Y; Yang A; Liang L; Cao J
J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
[TBL] [Abstract][Full Text] [Related]
16. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
17. Total flavone of
Yang BL; Zhu P; Li YR; Xu MM; Wang H; Qiao LC; Xu HX; Chen HJ
World J Gastroenterol; 2018 Aug; 24(30):3414-3425. PubMed ID: 30122880
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathway.
Zhao B; Lu YL; Yang Y; Hu LB; Bai Y; Li RQ; Zhang GY; Li J; Bi CW; Yang LB; Hu C; Lei YH; Wang QL; Liu ZM
Cancer Biomark; 2018 Feb; 21(3):613-620. PubMed ID: 29278879
[TBL] [Abstract][Full Text] [Related]
19. PAX3 silencing suppresses gastric cancer proliferation and angiogenesis via MET/PI3K signaling.
Lv WL; Hu YY; Li ZN; Zhang W; Pan Q
Neoplasma; 2020 Mar; 67(2):304-311. PubMed ID: 31847528
[TBL] [Abstract][Full Text] [Related]
20. Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control.
Antognelli C; Cecchetti R; Riuzzi F; Peirce MJ; Talesa VN
J Cell Mol Med; 2018 May; 22(5):2865-2883. PubMed ID: 29504694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]